Technical / White Paper
A Better Approach, for Better Pain Trials
Pain studies face unique challenges. For one, pain severity can only be truly assessed by the patients themselves. The controlled substances that are often used as experimental treatments in these studies bring stricter drug accountability requirements. Pain patients also face debilitating symptoms that can make participation in studies difficult. That's where Signant Health's solutions can help.
